Research has shown that Tregs can decrease lung levels of CXCL12 and inhibit collagen deposition and fibroblast recruitment via the CXCL12‐CXCR4 pathway, thus alleviating pulmonary fibrosis.201. Here, CXCL12 is linked to pulmonary fibrosis.